|Type||Publicly traded Aktieselskab|
|Traded as||OMX: COLO B|
|Key people||Lars Rasmussen (President and CEO), Michael Pram Rasmussen (Chairman)|
|Products||Ostomy bags, continence products, urology products, wound dressings|
|Revenue||DKK 10.17 billion (2010/2011)|
|Operating income||DKK 2.581 billion (2010/2011)|
|Profit||DKK 1.819 billion (2010/2011)|
|Total assets||DKK 9.218 billion (September 2011)|
|Total equity||DKK 4.478 billion (September 2011)|
|Employees||7,330 (FTE, average 2010/2011)|
Coloplast was founded in 1957, employs more than 7,500 people and operates around the world, with sales activities in 53 countries and production in Denmark, Hungary, France, China and the US. It has its headquarters in Humlebæk, Denmark. Its U.S. headquarters is in Minneapolis, Minnesota.
The company supplies products to hospitals and institutions as well as wholesalers and retailers. In selected markets, Coloplast is a direct supplier to consumers.
The company had revenues of DKK 10.17 billion in 2010/2011. Europe constitutes the biggest market with 73% of sales while 17% of sales are in North America and 10% in the rest of the world.
Coloplast is noted on the Danish Stock Exchange, and has for a number of years been represented among the 20 most traded shares in the country.
|This Danish corporation or company article is a stub. You can help Wikipedia by expanding it.|